Evidence map›Paper›PMID 35568199›Full record

ArticleThe Journal of biological chemistry2022

Binding of the erlin1/2 complex to the third intralumenal loop of IP

Xiaokong Gao, Caden G Bonzerato, Richard J H Wojcikiewicz

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. The ubiquitin-activating enzyme inhibitor TAK-243 activates store-operated CaBiochimica et biophysica acta. Molecular cell research · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Phosphorylation of Bok at Ser-8 blocks its ability to suppress IPCell communication and signaling : CCS · 2025
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Xiaokong GaoDepartment of Pharmacology, SUNY Upstate Medical University, Syracuse, New York, USA.
Caden G BonzeratoDepartment of Pharmacology, SUNY Upstate Medical University, Syracuse, New York, USA.
Richard J H WojcikiewiczDepartment of Pharmacology, SUNY Upstate Medical University, Syracuse, New York, USA. Electronic address: wojcikir@upstate.edu.
SUNY Upstate Medical University · US

Funding

Mechanism of IP3 receptor processing by the ERAD pathway and analysis of the IP3 receptor-erlin 1/2 complex-RNF170 axisR01DK107944 · NIDDK · UPSTATE MEDICAL UNIVERSITY · PI WOJCIKIEWICZ, RICHARD J H · 2017 to 2020
$1.6M
Significance of the novel Bok-IP3 receptor interactionR01GM121621 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI WOJCIKIEWICZ, RICHARD J H · 2017 to 2020
$1.2M
NIDDK NIH HHS R01 DK107944NIGMS NIH HHS R01 GM121621
6 · The paper itself

Abstract

Long-term activation of inositol 1,4,5-trisphosphate receptors (IP

Indexed as

Endoplasmic ReticulumInositol 1,4,5-Trisphosphate ReceptorsMembrane ProteinsUbiquitinAnimalsMiceUbiquitinationerlin-1 protein, mouseerlin-2 protein, mouseInositol 1,4,5-Trisphosphate ReceptorsItpr1 protein, mouseMembrane ProteinsUbiquitincalcium channelendoplasmic reticulum–associated degradationerlin1/2 complexinositol trisphosphate receptorprotein–protein interactionubiquitination

Identifiers

PMID35568199
PMCPMC9168715
OpenAlexW4280602831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.